Glaukos (GKOS) Capital Expenditures Growth (1y) (2015 - 2026)
Glaukos (GKOS) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -47.73% |
| 10 | Glaukos | 8.73 Bn | 8.62 Bn | 117.23 Mn | 104.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.28% |
| Dec 31, 2025 | 25.16% |
| Sep 30, 2025 | -59.24% |
| Jun 30, 2025 | 169.19% |
| Mar 31, 2025 | -12.55% |
| Dec 31, 2024 | -31.05% |
| Sep 30, 2024 | 3,214.88% |
| Jun 30, 2024 | -358.57% |
| Mar 31, 2024 | -8.47% |
| Dec 31, 2023 | 91.40% |
| Sep 30, 2023 | -99.35% |
| Jun 30, 2023 | -78.69% |
| Mar 31, 2023 | 1,015.67% |
| Dec 31, 2022 | -145.35% |
| Sep 30, 2022 | 165.40% |
| Jun 30, 2022 | -89.17% |
| Mar 31, 2022 | 848.28% |
| Dec 31, 2021 | 2,132.49% |
| Sep 30, 2021 | -2,336.07% |
| Jun 30, 2021 | 947.71% |